BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006;69:636-45. [PMID: 16122719 DOI: 10.1016/j.cardiores.2005.07.015] [Cited by in Crossref: 123] [Cited by in F6Publishing: 131] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Guizani I, Zidi W, Zayani Y, Nesrine F, Douik H, Sanhaji H, Mourali MS, Feki M, Allal-Elasmi M. Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study. Mol Biol Rep 2022. [PMID: 35960412 DOI: 10.1007/s11033-022-07742-1] [Reference Citation Analysis]
2 Shevchenko A, Prokofiev V, Konenkov V, Ragino Y. Association of inflammation, destruction and angiogenesis genes polymorphism with serum levels of matrix metalloproteinases 3 and 9 in patients with coronary atherosclerosis. 2022 Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB) 2022. [DOI: 10.1109/csgb56354.2022.9865622] [Reference Citation Analysis]
3 Lopez-Navarro ER, Park S, Willey JZ, Gutierrez J. Dolichoectasia: a brain arterial disease with an elusive treatment. Neurol Sci 2022. [PMID: 35441277 DOI: 10.1007/s10072-022-06078-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pérez-Is L, Collazos J, de la Fuente B, Morano L, Rivas-Carmenado M, Rodriguez M, Romero-Favela A, Fonseca-González GJ, Melón S, Valle-Garay E, Asensi V. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy. Sci Rep 2022;12:3828. [PMID: 35264591 DOI: 10.1038/s41598-022-07548-y] [Reference Citation Analysis]
5 Fan D, Zheng C, Wu W, Chen Y, Chen D, Hu X, Shen C, Chen M, Li R, Chen Y. MMP9 SNP and MMP SNP-SNP interactions increase the risk for ischemic stroke in the Han Hakka population. Brain Behav 2022;:e2473. [PMID: 34984852 DOI: 10.1002/brb3.2473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lu Y, Ussher N, Zhou Y, Jelinek H, Hambly B, Li A, McLachlan CS. Matrix Metalloproteinase-3 (MMP-3) Polymorphisms Are Associated with Prolonged ECG-Derived QTc Interval: A Cross-Sectional Study of the Australian Rural Population. J Pers Med 2021;11:705. [PMID: 34442348 DOI: 10.3390/jpm11080705] [Reference Citation Analysis]
7 Iannarelli NJ, MacNeil AJ, Dempster KS, Wade TJ, O'Leary DD. Serum MMP-3 and its association with central arterial stiffness among young adults is moderated by smoking and BMI. Physiol Rep 2021;9:e14920. [PMID: 34110720 DOI: 10.14814/phy2.14920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang Y, Meagher RB, Ambati S, Cheng H, Ma P, Phillips BG. Patients with Obstructive Sleep Apnea Have Altered Levels of Four Cytokines Associated with Cardiovascular and Kidney Disease, but Near Normal Levels with Airways Therapy. Nat Sci Sleep 2021;13:457-66. [PMID: 33790678 DOI: 10.2147/NSS.S282869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abriz AE, Rahbarghazi R, Nourazarian A, Avci ÇB, Mahboob SA, Rahnema M, Araghi A, Heidarzadeh M. Effect of docosahexaenoic acid plus insulin on atherosclerotic human endothelial cells. J Inflamm (Lond) 2021;18:10. [PMID: 33602249 DOI: 10.1186/s12950-021-00277-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Evseveva ME, Eremin MV, Rostovtseva MV, Sergeeva OV, Fursova EN, Rusidi VA, Galkova IY, Kudryavtseva VD. Phenotypes of early and favorable vascular aging in young people depending on the risk factors and presence of connective tissue dysplasia. Cardiovasc Ther Prev 2020;19:2524. [DOI: 10.15829/1728-8800-2020-2524] [Reference Citation Analysis]
11 Kuznetsova OO, Nikulina SY, Chernova AA, Maksimov VN. Association of polymorphism -1171 5A/6A of the matrix metalloproteinase gene type 3 (rs35068180) with dilated cardiomyopathy. Cardio Som 2020;11:6-9. [DOI: 10.26442/22217185.2020.3.200372] [Reference Citation Analysis]
12 Nikulina SY, Kuznecova OO, Chernova AA, Maksimov VN. Relationship of matrix metalloproteinase-3 -11715A/6A polymorphism (rs35068180) and dilated cardiomyopathy. Russ J Cardiol 2020;25:3960. [DOI: 10.15829/1560-4071-2020-3960] [Reference Citation Analysis]
13 Nikashin AN, Cherkashin DV, Andrianov VP, Fisun AJ. Morphofunctional features of the cardiovascular system in extreme specialists of the navy (depending on the polymorphism of the genes of the matrix metalloprotheinase 1 (MMP-1) and collagen 1 (COL1A1). Transl med (Print) 2020;7:32-43. [DOI: 10.18705/2311-4495-2020-7-4-32-43] [Reference Citation Analysis]
14 Hassanzadeh-Makoui R, Razi B, Aslani S, Imani D, Tabaee SS. The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis. BMC Cardiovasc Disord 2020;20:232. [PMID: 32429880 DOI: 10.1186/s12872-020-01510-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ghaffarzadeh A, Bagheri M, Khadem-vatani K, Abdi Rad I. Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A Genotypes With Coronary Artery Disease Risk Among Iranian Turks: . Journal of Cardiovascular Pharmacology 2019;74:420-5. [DOI: 10.1097/fjc.0000000000000727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Wu X, Chen L, Zeb F, Li C, Jiang P, Chen A, Xu C, Haq IU, Feng Q. Clock-Bmal1 mediates MMP9 induction in acrolein-promoted atherosclerosis associated with gut microbiota regulation. Environmental Pollution 2019;252:1455-63. [DOI: 10.1016/j.envpol.2019.06.042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
17 Pasipoularides A. Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 2: Pluridisciplinary perspective on their genetic and molecular origins. J Mol Cell Cardiol 2019;133:233-46. [PMID: 31175858 DOI: 10.1016/j.yjmcc.2019.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Zou F, Zhang J, Xiang G, Jiao H, Gao H. Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis. Can Respir J 2019;2019:9260495. [PMID: 30931075 DOI: 10.1155/2019/9260495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Baumert P, Hall EC, Erskine RM. The genetic association with exercise-induced muscle damage and muscle injury risk. Sports, Exercise, and Nutritional Genomics 2019. [DOI: 10.1016/b978-0-12-816193-7.00017-8] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Druk IV, Drokina OV, Smyalovsky DV, Smyalovsky VE, Shilova MA, Korsakov MV, Goltyapin VV. [Dissection of the internal carotid artery in a patient with connective tissue dysplasia having risk variants of several candidate genes]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:5-12. [PMID: 32207712 DOI: 10.17116/jnevro20191191225] [Reference Citation Analysis]
21 Cardoso AL, Fernandes A, Aguilar-Pimentel JA, de Angelis MH, Guedes JR, Brito MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, Schosserer M, Grillari J, Peterson P, Tuna BG, Dogan S, Meyer A, van Os R, Trendelenburg AU. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev 2018;47:214-77. [PMID: 30071357 DOI: 10.1016/j.arr.2018.07.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 205] [Article Influence: 38.8] [Reference Citation Analysis]
22 Žaliaduonytė-Pekšienė D, Lesauskaitė V, Liutkevičienė R, Tamakauskas V, Kviesulaitis V, Šinkūnaitė-Maršalkienė G, Šimonytė S, Mačiulskytė S, Tamulevičiūtė-Prascienė E, Gustienė O, Tamošiūnas A, Žaliūnas R. Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development. J Renin Angiotensin Aldosterone Syst 2017;18:1470320317739987. [PMID: 29141503 DOI: 10.1177/1470320317739987] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Djuric T, Zivkovic M. Overview of MMP Biology and Gene Associations in Human Diseases. The Role of Matrix Metalloproteinase in Human Body Pathologies 2017. [DOI: 10.5772/intechopen.70265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
24 Lewallen EA, Salib CG, Trousdale WH, Berry CE, Hanssen GM, Robin JX, Tibbo ME, Viste A, Reina N, Morrey ME, Sanchez-Sotelo J, Hanssen AD, Berry DJ, van Wijnen AJ, Abdel MP. Molecular pathology of total knee arthroplasty instability defined by RNA-seq. Genomics 2018;110:247-56. [PMID: 29174847 DOI: 10.1016/j.ygeno.2017.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Li T, Lv Z, Jing JJ, Yang J, Yuan Y. Matrix metalloproteinase family polymorphisms and the risk of aortic aneurysmal diseases: A systematic review and meta-analysis. Clin Genet 2018;93:15-32. [PMID: 28485889 DOI: 10.1111/cge.13050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
26 Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45 [PMID: 28573088 DOI: 10.5501/wjv.v6.i2.36] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Alp E, Yilmaz A, Tulmac M, Ugras Dikmen A, Cengel A, Yalcin R, Menevse ES. Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study. Kaohsiung J Med Sci 2017;33:78-85. [PMID: 28137415 DOI: 10.1016/j.kjms.2016.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
28 Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS. Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype. J Stroke Cerebrovasc Dis 2017;26:368-75. [PMID: 27793533 DOI: 10.1016/j.jstrokecerebrovasdis.2016.09.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
29 Kondapalli MS, Galimudi RK, Gundapaneni KK, Padala C, Cingeetham A, Gantala S, Ali A, Shyamala N, Sahu SK, Nallari P, Hanumanth SR. MMP 1 circulating levels and promoter polymorphism in risk prediction of coronary artery disease in asymptomatic first degree relatives. Gene 2016;595:115-20. [PMID: 27693213 DOI: 10.1016/j.gene.2016.09.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Shaik-Dasthagirisaheb YB, Mekasha S, He X, Gibson FC 3rd, Ingalls RR. Signaling events in pathogen-induced macrophage foam cell formation. Pathog Dis 2016;74:ftw074. [PMID: 27481727 DOI: 10.1093/femspd/ftw074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
31 Li YT, Wang YC, Lee HL, Lu MC, Yang SF. Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia. Int J Med Sci 2016;13:638-45. [PMID: 27499696 DOI: 10.7150/ijms.16187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
32 Li YY, Yang XX, Zhou YH, Gong G, Geng HY, Kim HJ, Zhou CW, Qian Y, Wang XM, Wu J. Matrix metalloproteinase-9 Gene-1562C>T Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis of 5468 Subjects. Front Physiol 2016;7:212. [PMID: 27375491 DOI: 10.3389/fphys.2016.00212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Wang XL, Zhou YL, Sun W, Li L. Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway. PLoS One 2016;11:e0153919. [PMID: 27120457 DOI: 10.1371/journal.pone.0153919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
34 El Khoury L, Ribbans WJ, Raleigh SM. MMP3 and TIMP2 gene variants as predisposing factors for Achilles tendon pathologies: Attempted replication study in a British case-control cohort. Meta Gene 2016;9:52-5. [PMID: 27222816 DOI: 10.1016/j.mgene.2016.03.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
35 Do AN, Lynch AI, Claas SA, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Tiwari HK, Arnett DK, Irvin MR. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. J Hum Hypertens 2016;30:549-54. [PMID: 26791477 DOI: 10.1038/jhh.2015.121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
36 Liang J, Zhao T, Yang J, Li W, Zhang F, Zhang S, Huang Z, Lin R, Zhang X. MMP-9 gene polymorphisms (rs3918242, rs3918254 and rs4810482) and the risk of psoriasis vulgaris: No evidence for associations in a Chinese Han population. Immunol Lett 2015;168:343-8. [PMID: 26554609 DOI: 10.1016/j.imlet.2015.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
37 Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS. Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese. Int J Neurosci 2016;126:936-41. [PMID: 26314579 DOI: 10.3109/00207454.2015.1088013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Collazos J, Asensi V, Martin G, Montes AH, Suárez-Zarracina T, Valle-Garay E. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions. Clin Exp Immunol 2015;182:213-9. [PMID: 26206176 DOI: 10.1111/cei.12686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
39 Teplyakov AT, Berezikova EN, Shilov SN, Grakova EV, Torim YY, Efremov AV, Safronov ID, Pustovetova MG, Karpov RS. [Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure]. Ter Arkh 2015;87:8-12. [PMID: 26087627 DOI: 10.17116/terarkh20158748-12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
40 da Rocha RF, De Bastiani MA, Klamt F. Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis. Cell Biochem Biophys 2014;70:831-9. [PMID: 24771407 DOI: 10.1007/s12013-014-9987-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
41 Grzela K, Litwiniuk M, Zagorska W, Grzela T. Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9. Arch Immunol Ther Exp (Warsz) 2016;64:47-55. [PMID: 26123447 DOI: 10.1007/s00005-015-0345-y] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
42 Ghayor C, Gjoksi B, Siegenthaler B, Weber FE. N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling. Inflamm Res 2015;64:527-36. [PMID: 26047594 DOI: 10.1007/s00011-015-0833-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
43 Xu X, Xiao L, Xiao P, Yang S, Chen G, Liu F, Kanwar YS, Sun L. A glimpse of matrix metalloproteinases in diabetic nephropathy. Curr Med Chem. 2014;21:3244-3260. [PMID: 25039784 DOI: 10.2174/0929867321666140716092052] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
44 Ma J, You C. Association between matrix metalloproteinase-3 gene polymorphism and moyamoya disease. Journal of Clinical Neuroscience 2015;22:479-82. [DOI: 10.1016/j.jocn.2014.08.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Juan Z, Wei-Guo Z, Heng-Liang S, Da-Guo W. Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis. Curr Ther Res Clin Exp 2015;77:40-5. [PMID: 26082814 DOI: 10.1016/j.curtheres.2014.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
46 Vašků A, Bienertová-vašků J, Pařenica J, Pávková Goldbergová M, Novák J, Chmelíková M, Honsová D, Lipkova J, Kala P, Spinar J. Central Pulse Pressure and Variability in Matrix Metalloproteinases Genes and Their Inhibitors in Patients With Ischemic Heart Disease. Physiol Res. [DOI: 10.33549/physiolres.932924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
47 Bahrehmand F, Vaisi-raygani A, Kiani A, Rahimi Z, Tavilani H, Ardalan M, Vaisi-raygani H, Shakiba E, Pourmotabbed T. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress. Lupus 2015;24:597-605. [DOI: 10.1177/0961203314559085] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
48 Guan X, Wang X, Luo H, Wu J, Zhang X. Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk. Med Sci Monit. 2014;20:2269-2274. [PMID: 25391977 DOI: 10.12659/msm.892413] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
49 Leontyev S, Misfeld M, Mohr FW. [Aneurysms of the ascending aorta and aortic arch]. Chirurg 2014;85:758, 760-66. [PMID: 25200626 DOI: 10.1007/s00104-014-2716-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
50 Chehaibi K, Hrira MY, Nouira S, Maatouk F, Hamda KB, Slimane MN. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population. Journal of the Neurological Sciences 2014;342:107-13. [DOI: 10.1016/j.jns.2014.04.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
51 Ariely R, Evans K, Mills T. Heart failure in China: a review of the literature. Drugs 2013;73:689-701. [PMID: 23625274 DOI: 10.1007/s40265-013-0057-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
52 Singh K, Agrawal NK, Gupta SK, Mohan G, Chaturvedi S, Singh K. Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity. The International Journal of Lower Extremity Wounds 2014;13:94-102. [DOI: 10.1177/1534734614534980] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
53 Martin G, Asensi V, Montes AH, Collazos J, Alvarez V, Carton JA, Taboada F, Valle-Garay E. Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients. Sci Rep 2014;4:5002. [PMID: 24833564 DOI: 10.1038/srep05002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
54 Wen D, Du X, Nie S, Dong J, Ma C. Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis. Mol Neurobiol 2014;50:979-85. [DOI: 10.1007/s12035-014-8687-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
55 Duellman T, Warren C, Yang J. Single nucleotide polymorphism-specific regulation of matrix metalloproteinase-9 by multiple miRNAs targeting the coding exon. Nucleic Acids Res 2014;42:5518-31. [PMID: 24627221 DOI: 10.1093/nar/gku197] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
56 Vecoli C, Adlerstein D, Shehi E, Bigazzi F, Sampietro T, Foffa I, Carpeggiani C, L'abbate A, Andreassi MG. Genetic score based on high-risk genetic polymorphisms and early onset of ischemic heart disease in an Italian cohort of ischemic patients. Thromb Res 2014;133:804-10. [PMID: 24656450 DOI: 10.1016/j.thromres.2014.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
57 Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer. Tumour Biol 2014;35:1351-6. [PMID: 24357512 DOI: 10.1007/s13277-013-1181-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
58 Lynch AI, Irvin MR, Davis BR, Ford CE, Eckfeldt JH, Arnett DK. Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT. Int J Hypertens 2013;2013:578578. [PMID: 24288596 DOI: 10.1155/2013/578578] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
59 Singh K, Agrawal NK, Gupta SK, Singh K. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds 2013;12:199-204. [PMID: 24043671 DOI: 10.1177/1534734613493289] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
60 Faria A, Costa D, Criado B, Albuquerque A, Escórcio C. Phenotypes of myocardial blood perfusion related to the genetic variations of metalloproteinases 3 (MMP3) and 9 (MMP9). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2013;1:119-29. [DOI: 10.1080/21681163.2013.769749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:928315. [PMID: 23840100 DOI: 10.1155/2013/928315] [Cited by in Crossref: 235] [Cited by in F6Publishing: 266] [Article Influence: 23.5] [Reference Citation Analysis]
62 Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res. 2013;113:252-265. [PMID: 23748430 DOI: 10.1161/circresaha.113.301562] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 12.1] [Reference Citation Analysis]
63 Faria A, Costa D, Criado B, Albuquerque A, Escórcio C. Left ventricular function influenced by MMP3 gene 5A/6A polymorphism (rs3025058): a gated-SPECT study. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2013;1:89-99. [DOI: 10.1080/21681163.2013.769748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Huang R, Deng L, Shen A, Liu J, Ren H, Xu DL. Associations of MMP1, 3, 9 and TIMP3 genes polymorphism with isolated systolic hypertension in Chinese Han population. Int J Med Sci. 2013;10:840-847. [PMID: 23794948 DOI: 10.7150/ijms.5728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
65 Sewelam NI, Radwan ER, Andraos AW, Ibrahim BE, Wilson MM. Association between the polymorphisms of matrix metalloproteinases 9 and 3 genes and risk of myocardial infarction in Egyptian patients. Egyptian Journal of Medical Human Genetics 2013;14:143-8. [DOI: 10.1016/j.ejmhg.2013.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
66 Tsai E, Wang Y, Lin C, Lin W, Hsi E, Wu M, Juo SH. A microRNA-520 mirSNP at the MMP2 gene influences susceptibility to endometriosis in Chinese women. J Hum Genet 2013;58:202-9. [DOI: 10.1038/jhg.2013.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
67 Sakowicz A, Fendler W, Lelonek M, Sakowicz B, Pietrucha T. Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age. Biochem Genet 2013;51:230-42. [PMID: 23274712 DOI: 10.1007/s10528-012-9558-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
68 Yüksel M, Kuzu-Okur H, Velioğlu-Öğünç A, Pelin Z. Matrix Metalloproteinase-9 Level and Gene Polymorphism in Sleep Disordered Breathing Patients with or without Cardiovascular Disorders. Balkan Med J 2013;30:8-12. [PMID: 25207060 DOI: 10.5152/balkanmedj.2012.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
69 Sakowicz A, Fendler W, Lelonek M, Pietrucha T. Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. Arch Med Sci 2010;6:160-7. [PMID: 22371740 DOI: 10.5114/aoms.2010.13887] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
70 Spurthi KM, Galimudi RK, Srilatha G, Sahu SK, Nallari P, Hanumanth SR. Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis. Genet Test Mol Biomarkers 2012;16:850-4. [PMID: 22809399 DOI: 10.1089/gtmb.2011.0299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
71 Hall JL, Duprez DA, Barac A, Rich SS. A Review of Genetics, Arterial Stiffness, and Blood Pressure in African Americans. J of Cardiovasc Trans Res 2012;5:302-8. [DOI: 10.1007/s12265-012-9362-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
72 Lavall D, Schäfers HJ, Böhm M, Laufs U. Aneurysms of the ascending aorta. Dtsch Arztebl Int 2012;109:227-33. [PMID: 22532815 DOI: 10.3238/arztebl.2012.0227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
73 Barish GD, Yu RT, Karunasiri MS, Becerra D, Kim J, Tseng TW, Tai LJ, Leblanc M, Diehl C, Cerchietti L, Miller YI, Witztum JL, Melnick AM, Dent AL, Tangirala RK, Evans RM. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab 2012;15:554-62. [PMID: 22465074 DOI: 10.1016/j.cmet.2012.02.012] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 8.2] [Reference Citation Analysis]
74 Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif. 2012;45:189-198. [PMID: 22452352 DOI: 10.1111/j.1365-2184.2012.00820.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
75 Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2011;63:3988-97. [PMID: 21953143 DOI: 10.1002/art.30615] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
76 Chiang T, Shyu L, Tsao TY, Chien M, Tsao S, Lee Y, Yang S. Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine 2012;50. [DOI: 10.1515/cclm.2011.805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
77 Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease. Coron Artery Dis 2011;22:388-93. [PMID: 21606841 DOI: 10.1097/MCA.0b013e3283478d40] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
78 Mohammad Beigi M, Behjati M, Mohabatkar H. Prediction of metalloproteinase family based on the concept of Chou’s pseudo amino acid composition using a machine learning approach. J Struct Funct Genomics 2011;12:191-7. [DOI: 10.1007/s10969-011-9120-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
79 Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, Coletta M. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med 2012;33:119-208. [PMID: 22100792 DOI: 10.1016/j.mam.2011.10.015] [Cited by in Crossref: 157] [Cited by in F6Publishing: 143] [Article Influence: 13.1] [Reference Citation Analysis]
80 Chuang SY, Yang SH, Chen TY, Pang JH. Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells. Eur J Pharmacol 2011;670:419-26. [PMID: 21925496 DOI: 10.1016/j.ejphar.2011.08.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
81 Cheung Y, Hong W, Chan K, Wong SJ. Modulating effects of matrix metalloproteinase-3 and -9 polymorphisms on aortic stiffness and aortic root dilation in patients after tetralogy of Fallot repair. International Journal of Cardiology 2011;151:214-7. [DOI: 10.1016/j.ijcard.2010.05.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
82 Sri Manjari K, Krishnaveni D, Vidyasagar A, Prabhakar B, Jyothy A, Nallari P, Venkateshwari A. Role of matrix metalloproteinase 3 gene promoter polymorphism in chronic pancreatitis. Indian J Gastroenterol 2011;30:217-20. [PMID: 21948134 DOI: 10.1007/s12664-011-0125-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Zhang R, Pan X, Huang Z, Weber GF, Zhang G. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One. 2011;6:e23831. [PMID: 21909361 DOI: 10.1371/journal.pone.0023831] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
84 Tanner RM, Lynch AI, Brophy VH, Eckfeldt JH, Davis BR, Ford CE, Boerwinkle E, Arnett DK. Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension. PLoS One 2011;6:e23609. [PMID: 21887284 DOI: 10.1371/journal.pone.0023609] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
85 Maqbool A, Keswani A, Galloway S, O'Regan DJ, Ball SG, Turner NA, Porter KE. MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion. J Surg Res 2012;175:343-9. [PMID: 21601886 DOI: 10.1016/j.jss.2011.03.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
86 Yamakawa N, Uchida T, Matthay MA, Makita K. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011;300:L516-25. [PMID: 21257730 DOI: 10.1152/ajplung.00118.2010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
87 Kure M, Pezzolesi MG, Poznik GD, Katavetin P, Skupien J, Dunn JS, Mychaleckyj JC, Warram JH, Krolewski AS. Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes. Mol Genet Metab 2011;103:60-5. [PMID: 21277817 DOI: 10.1016/j.ymgme.2011.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
88 Hsia TY, Ringewald JM, Stroud RE, Forbus GA, Bradley SM, Chung WK, Spinale FG. Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy. Eur J Heart Fail 2011;13:271-7. [PMID: 21147820 DOI: 10.1093/eurjhf/hfq184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
89 Kang W, Connor J, Yan X, Neely B, Carney E, Ellwanger J, Huang Y. A modified technique improved histology similarity to human intracranial aneurysm in rabbit aneurysm model. Neuroradiol J 2010;23:616-21. [PMID: 24148684 DOI: 10.1177/197140091002300512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
90 Lien L, Hsieh Y, Bai C, Chen W, Chiu H, Hsieh F, Shyu K, Chiou H, Hsu CY. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 2010;212:595-600. [DOI: 10.1016/j.atherosclerosis.2010.05.040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
91 Yoo M, Kim H, Qing Y, Kim J, Kim S. Matrix Metalloproteinase-3 Gene Polymorphisms (A(-267)G, A658G, T813C) is Associated with Type 2 Diabetes in Koreans. Journal of Life Science 2010;20:602-606. [DOI: 10.5352/jls.2010.20.4.602] [Reference Citation Analysis]
92 Souslova V, Townsend PA, Mann J, van der Loos CM, Motterle A, D'Acquisto F, Mann DA, Ye S. Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB. PLoS One 2010;5:e9902. [PMID: 20360864 DOI: 10.1371/journal.pone.0009902] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
93 Drozdzik A, Kurzawski M, Lener A, Kozak M, Banach J, Drozdzik M. Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth. Journal of Periodontal Research 2010;45:143-7. [DOI: 10.1111/j.1600-0765.2009.01221.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
94 Lee JE, Choi YK, Seo HA, Jeon JH, Jeong JY, Moon SS, Kim JG, Kim BW, Kim SW, Min Yoo, Kim JY, Lee IK. Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. Diabetes Res Clin Pract 2010;88:87-96. [PMID: 20092902 DOI: 10.1016/j.diabres.2010.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
95 Koch W, de Waha A, Hoppmann P, Schömig A, Kastrati A. Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: Case–control study and a meta-analysis. Atherosclerosis 2010;208:171-6. [DOI: 10.1016/j.atherosclerosis.2009.08.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
96 Volcik KA, Campbell S, Chambless LE, Coresh J, Folsom AR, Mosley TH, Ni H, Wagenknecht LE, Wasserman BA, Boerwinkle E. MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study. Atherosclerosis 2010;210:188-93. [PMID: 20064641 DOI: 10.1016/j.atherosclerosis.2009.12.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
97 Pico F, Jacob M, Labreuche J, Soufir N, Touboul P, Benessiano J, Cambien F, Grandchamp B, Michel J, Amarenco P. Matrix metalloproteinase-3 and intracranial arterial dolichoectasia. Ann Neurol 2010;67:508-15. [DOI: 10.1002/ana.21922] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
98 Dhillon O, Khan S, Narayan H, Ng K, Mohammed N, Quinn P, Squire I, Davies J, Ng L. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clinical Science 2010;118:249-57. [DOI: 10.1042/cs20090226] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
99 Clee SM. A role for MMP-3 genetic variation in atherosclerosis susceptibility? Atherosclerosis 2010;208:30-1. [PMID: 19815209 DOI: 10.1016/j.atherosclerosis.2009.09.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
100 Derouette J, Wong C, Burnier L, Morel S, Sutter E, Galan K, Brisset AC, Roth I, Chadjichristos CE, Kwak BR. Molecular role of Cx37 in advanced atherosclerosis: A micro-array study. Atherosclerosis 2009;206:69-76. [DOI: 10.1016/j.atherosclerosis.2009.02.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
101 Jefferis BJ, Whincup P, Welsh P, Wannamethee G, Rumley A, Lennon L, Thomson A, Lawlor D, Carson C, Ebrahim S, Lowe G. Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 2010;208:557-63. [PMID: 19748093 DOI: 10.1016/j.atherosclerosis.2009.08.018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
102 Kurzawski M, Modrzejewski A, Pawlik A, Droździk M. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins. Clin Exp Dermatol 2009;34:613-7. [PMID: 19508478 DOI: 10.1111/j.1365-2230.2008.03166.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
103 Busti C, Falcinelli E, Momi S, Gresele P. Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 2010;5:13-25. [PMID: 19626421 DOI: 10.1007/s11739-009-0283-y] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 5.0] [Reference Citation Analysis]
104 Yue H, Leng N, Wu Z, Li H, Li X, Zhu P. Expression of CD147 on phorbol-12-myris-tate-13-acetate (PMA)-treated U937 cells differentiating into foam cells. Archives of Biochemistry and Biophysics 2009;485:30-4. [DOI: 10.1016/j.abb.2009.01.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
105 Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res. 2009;81:637-648. [PMID: 19098299 DOI: 10.1093/cvr/cvn353] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 8.1] [Reference Citation Analysis]
106 Djurić T, Zivković M, Radak D, Jekić D, Radak S, Stojković L, Raicević R, Stanković A, Alavantić D. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 2008;41:1326-9. [PMID: 18801353 DOI: 10.1016/j.clinbiochem.2008.08.081] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
107 Nho YK, Ha E, Yu KI, Chung JH, Wook NC, Chung IS, Lee MY, Shin DH. Matrix metalloproteinase-1 promoter is associated with body mass index in Korean population with aged greater or equal to 50 years. Clin Chim Acta 2008;396:14-7. [PMID: 18602909 DOI: 10.1016/j.cca.2008.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
108 Kaludercic N, Lindsey ML, Tavazzi B, Lazzarino G, Paolocci N. Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. Cardiovasc Ther 2008;26:24-37. [PMID: 18466418 DOI: 10.1111/j.1527-3466.2007.00034.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
109 Ikeda K, Ihara K, Yamaguchi K, Muneuchi J, Ohno T, Mizuno Y, Hara T. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatr Res 2008;63:182-5. [PMID: 18091353 DOI: 10.1203/PDR.0b013e31815ef224] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
110 Mannello F. Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thromb Vasc Biol 2008;28:611-4. [PMID: 18354094 DOI: 10.1161/ATVBAHA.107.159608] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
111 Borghese B, Chiche JD, Vernerey D, Chenot C, Mir O, Bijaoui G, Bonaiti-Pellié C, Chapron C. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod 2008;23:1207-13. [PMID: 18308831 DOI: 10.1093/humrep/den007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
112 Mukhopadhyay S, Tulis DA. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. Cardiovasc Hematol Agents Med Chem 2007;5:311-8. [PMID: 17979695 DOI: 10.2174/187152507782109917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
113 Tiwari R, Singh V, Barthwal M. Macrophages: An elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 2008;28:483-544. [DOI: 10.1002/med.20118] [Cited by in Crossref: 104] [Cited by in F6Publishing: 112] [Article Influence: 6.9] [Reference Citation Analysis]
114 Decock J, Paridaens R, Ye S. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin Genet. 2008;73:197-211. [PMID: 18177467 DOI: 10.1111/j.1399-0004.2007.00946.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
115 Lin TH, Chiu HC, Lee YT, Su HM, Juo SH, Voon WC, Lai WT, Sheu SH. The C-allele of tissue inhibitor of metalloproteinases 2 is associated with increased magnitude of QT dispersion prolongation in elderly Chinese - 4-year follow-up study. Clin Chim Acta 2007;386:87-93. [PMID: 17868665 DOI: 10.1016/j.cca.2007.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
116 Jguirim-Souissi I, Jelassi A, Addad F, Hassine M, Najah M, Ben Hamda K, Maatouk F, Ben Farhat M, Bouslema A, Rouis M, Slimane MN. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease. Am J Cardiol 2007;100:23-7. [PMID: 17599435 DOI: 10.1016/j.amjcard.2007.01.069] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
117 Bauters C, Lamblin N, Ennezat PV, Mycinski C, Tricot O, Nugue O, Segrestin B, Hannebicque G, Agraou B, Polge AS, de Groote P, Helbecque N, Amouyel P; REVE Investigators. A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems. Am Heart J 2007;153:641-8. [PMID: 17383306 DOI: 10.1016/j.ahj.2007.01.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
118 Barlic J, Murphy PM. Chemokine regulation of atherosclerosis. J Leukoc Biol 2007;82:226-36. [PMID: 17329566 DOI: 10.1189/jlb.1206761] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
119 Powell JT. Genes predisposing to rapid aneurysm growth. Ann N Y Acad Sci 2006;1085:236-41. [PMID: 17182940 DOI: 10.1196/annals.1383.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
120 Dalepiane VL, Silvello DN, Paludo CA, Roisenberg I, Simon D. Matrix metalloproteinase gene polymorphisms in patients with coronary artery disease. Genet Mol Biol 2007;30:505-10. [DOI: 10.1590/s1415-47572007000400001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
121 Kunz J. Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 2007;53:63-73. [PMID: 17047333 DOI: 10.1159/000096351] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
122 Newby AC. Do metalloproteinases destabilize vulnerable atherosclerotic plaques? Current Opinion in Lipidology 2006;17:556-61. [DOI: 10.1097/01.mol.0000245262.48258.b4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
123 Tjwa M, Carmeliet P, Moons L. Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis. Circulation 2006;113:1929-32. [DOI: 10.1161/circulationaha.106.619569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]